These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


264 related items for PubMed ID: 4755631

  • 1. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
    Clément F.
    Schweiz Med Wochenschr; 1973 Oct 06; 103(40):1369-77. PubMed ID: 4755631
    [No Abstract] [Full Text] [Related]

  • 2. [The treatment of disseminated lupus erythematosus. So-called immunosuppressive drugs].
    Clément F.
    Schweiz Med Wochenschr; 1970 Feb 14; 100(7):333-5. PubMed ID: 4189917
    [No Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA, Lambert PH.
    Ther Umsch; 1971 Sep 14; 28(9):579-85. PubMed ID: 5122520
    [No Abstract] [Full Text] [Related]

  • 4. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA, McCune WJ.
    Rheum Dis Clin North Am; 1994 Feb 14; 20(1):265-99. PubMed ID: 8153402
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive therapy in neurological diseases.
    Cendrowski W, Riekkinen PJ, Rinne UK.
    Ann Clin Res; 1974 Dec 14; 6(6):323-9. PubMed ID: 4375431
    [No Abstract] [Full Text] [Related]

  • 6. Immunosuppressive therapy in systemic lupus erythematosus.
    Russell AS, Bretscher PA.
    J Rheumatol Suppl; 1987 Jun 14; 14 Suppl 13():194-8. PubMed ID: 3302253
    [Abstract] [Full Text] [Related]

  • 7. [2 cases of systemic lupus erythematosus treated with immunosuppressive agents].
    Laugier P, Hunziker N.
    Bull Soc Fr Dermatol Syphiligr; 1970 Jun 14; 77(3):410-1. PubMed ID: 5510737
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
    Kampf D, Baethke R.
    Dtsch Med Wochenschr; 1974 Jun 28; 99(26):1420-3. PubMed ID: 4135099
    [No Abstract] [Full Text] [Related]

  • 9. [Lupus erythematosus, modern aspects (author's transl)].
    Canavese JC.
    Schweiz Rundsch Med Prax; 1977 May 10; 66(19):565-72. PubMed ID: 69300
    [No Abstract] [Full Text] [Related]

  • 10. [Lupus erythematosus in childhood].
    Pulgram A, Zimprich H, Weippl G.
    Wien Klin Wochenschr; 1973 Feb 02; 85(5):67-70. PubMed ID: 4685491
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S, Ghelerter L, Matei I, Brunazian G.
    Stud Cercet Med Interna; 1969 Feb 02; 10(2):147-53. PubMed ID: 5344004
    [No Abstract] [Full Text] [Related]

  • 12. Innovative management of lupus erythematosus.
    Knott HM, Martínez JD.
    Dermatol Clin; 2010 Jul 02; 28(3):489-99. PubMed ID: 20510759
    [Abstract] [Full Text] [Related]

  • 13. [Results of immunosuppressive treatment of visceral lupus erythematosus].
    Japa J, Kardaszewicz E.
    Pol Tyg Lek; 1969 Oct 06; 24(40):1534-6. PubMed ID: 5365671
    [No Abstract] [Full Text] [Related]

  • 14. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM, Klatt R, Stobbe H, Apostoloff E, Jendrusch C.
    Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract] [Full Text] [Related]

  • 15. Drug therapy: immunosuppressive agents (second of two parts).
    Kaplan SR, Calabresi P.
    N Engl J Med; 1973 Dec 06; 289(23):1234-6. PubMed ID: 4594161
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
    Cruchaud A, Pometta D, Rousso C.
    Helv Med Acta; 1967 Dec 06; 34(1):5-22. PubMed ID: 4173836
    [No Abstract] [Full Text] [Related]

  • 17. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT, Houghton K, Bond M, Senger C, Tucker LB.
    J Rheumatol; 2010 Aug 01; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract] [Full Text] [Related]

  • 18. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy.
    Rood MJ, Borggreve SE, Huizinga TW.
    J Rheumatol; 2000 Aug 01; 27(8):2057-9. PubMed ID: 10955362
    [No Abstract] [Full Text] [Related]

  • 19. [Multicenter cooperative study of immunosuppressive therapy of systemic lupus erythematosus--a report of Therapy Research Division of Research Committee for Autoimmune Diseases, the Ministry of Health and Welfare].
    Ichikawa Y, Tanaka H, Hirose S, Yokohari R, Tsunematsu T.
    Ryumachi; 1988 Aug 01; 28(4):230-9. PubMed ID: 3055347
    [No Abstract] [Full Text] [Related]

  • 20. [Combined immunosuppressive treatment of systemic lupus erythematosus].
    Pluzańska A, Dmochowska M, Orlowski Z, Pawlowski J, Krauze-Jaworska H, Krykowski E, Zebrowski A.
    Pol Arch Med Wewn; 1974 Sep 01; 52(3):275-81. PubMed ID: 4418141
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.